Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for mTOR protein
Most Correlated Studies
- CD4 T-cells with MTOR, ZAP70 silencing, or treated with Rapamycin or Cyclosporin A
- Melanoma cell line treated with MEK and PI3K/mTOR inhibitors
- Prostate cancer cells treated with mTOR inhibitors
- Melanoma Me13 cells treated with MEK1/2, PI3K/mTOR, mTOR, and BRAF V600E inhibitors
- Multiple myeloma OPM-2 cells treated with PI3K/mTOR inhibitor VS-5584 (SB2343)
Most Relevant Literature
- Discovery of the First Raptor (Regulatory-Associated Protein of mTOR) Inhibitor as a New Type of Ant…
- Regulation of mTOR Signaling: Emerging Role of Cyclic Nucleotide-Dependent Protein Kinases and Impli…
- Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in …
- KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy.
- Upregulated YB-1 protein promotes glioblastoma growth through a YB-1/CCT4/mLST8/mTOR pathway.
Most Relevant Clinical Trials
- Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling
- POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus
- Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic …
- Nutritional and Contractile Regulation of Muscle Growth
- Does Protein Restriction Inhibit Prostrate Cancer Growth
